Novartis posts Cosentyx nail psoriasis and imatinib results; Piqray label updatedOct 30Weekly roundup, 8 itemsalpelisibeverolimusUpdated
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Inhibikase names Kailera CMO Scott Wasserman to board, Berman resignsOct 20PeopleIKT-001Inhibikase Therapeutics
Cogent Biosciences reports Q2 2026 results, two bezuclastinib PDUFA dates aheadAug 10Quarterly updatebezuclastinibCogent Biosciences, Inc.
FDA grants orphan drug status to Inhibikase's IKT-001 for PAHJul 23Regulatory milestoneIKT-001Inhibikase Therapeutics
Novartis posts pelacarsen Phase 3 apheresis results, updates three drug labelsJul 17Weekly roundup, 8 itemscarbamazepineimatinib
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant